Mov Disord Vol 31, Suppl 2 Archives - Page 61 of 207 - MDS Abstracts

2016 International Congress
Clinicopathological characteristics of co-existant Parkinson’s disease and corticobasal degeneration: A case study
K. Andruska, C. Kilbane, E. Plowey, K. Poston (Stanford, CA, USA)
Objective: Parkinsonism is characterized by bradykinesia, rigidity, rest tremor, and postural instability. The most common cause of parkinsonism is Parkinson's disease (PD) and, rarely, Parkinson-plus…
2016 International Congress
The relationship between the cognitive phenotype and 5-HT2A receptor in PD with visual hallucinations
S.S. Cho, A.P. Strafella, S. Duff-Canning, M. Zurowski, A.C. Vijverman, V. Bruno, C. de Aquino, M. Criaud, P.M. Rusjan, S. Houle, S.H. Fox (Toronto, ON, Canada)
Objective: The aim of this study was to investigate the relationship between cognitive phenotype and 5-HT2A receptor availability in PD patients with visual hallucinations (VH).…
2016 International Congress
The prevalence of gastrointestinal disorders and non-motor symptoms in a cohort of patients with Parkinson’s disease
P.J. Hobson, J.R. Meara (Rhyl, United Kingdom)
Objective: The aim of this investigation was to estimate the prevalence of gastrointestinal disorders (GID) and non-motor symptoms (NMS) in a cohort of a cohort…
2016 International Congress
Anxiety and freezing of gait: A new perspective for early intervention
K.A. Ehgoetz Martens, J.M. Hall, M. Gilat, M.J. Georgiades, C.C. Walton, S.J.G. Lewis (Camperdown, Australia)
Objective: The current study evaluated (i) whether PD+FOG have greater anxiety compared to PD-NF, and (ii) whether anxiety in PD is related to executive dysfunction,…
2016 International Congress
Chin EMG variance and dream-enactment behavior during polysomnography in Parkinson’s disease
Y. Shen, K.P. Xiong, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)
Objective: The aim of this study was to exam relationships between REM sleep muscle atonia (RSWA), dream-enactment behavior(DEB) and clinical characteristics in Parkinson's disease (PD)…
2016 International Congress
Risks and predictive factors for pneumonia amongst Parkinson’s disease patients with dysphagia
K.H. Goh, H.L. Ng, K.Y. Tay, S. Acharyya, S.Y.E. Ng, J.P.L. Boo, A.H.J. Kooi, W. Li, W.L. Au, L.C.S. Tan (Singapore, Singapore)
Objective: To evaluate (1) Time to hospitalisation for pneumonia/choking in Parkinson's disease (PD) patients. (2) Demographic and clinical features that associated with pneumonia/choking. Background: Dysphagia…
2016 International Congress
Quality of life after subthalamic stimulation depends on non-motor symptoms in Parkinson’s disease
H.S. Dafsari, L. Weiss, M. Silverdale, P. Reddy, A. Rizos, M. Samuel, E. Perrier, J. Evans, K. Ashkan, J.N. Petry-Schmelzer, V. Visser-Vandewalle, A. Antonini, P. Martinez-Martin, K.R. Chaudhuri, L. Timmermann (Cologne, Germany)
Objective: To investigate non-motor symptoms (NMS) to find contributing factors for quality of life (QoL) outcome after subthalamic nucleus (STN) deep brain stimulation (DBS) in…
2016 International Congress
Associated and predictive factors of depressive symptoms in patients with Parkinson’s disease
K. Zhu, J.J. Van Hilten, J. Marinus (Leiden, Netherlands)
Objective: The aim of this longitudinal study is to examine which variables are associated with depressive symptoms in Parkinson's disease (PD), as well as to…
2016 International Congress
Clinical and biological predictors of excessive daytime sleepiness in early Parkinson’s disease
T. Simuni, J. Long, C. Caspell-Garcia, C.S. Coffey, W. Oertel, S. Lasch, K. Marek, On behalf of the PPMI Sleep Working Group (Chicago, IL, USA)
Objective: To examine longitudinal change in excessive daytime sleepiness (EDS) and to determine clinical and biological variables that predict new onset EDS in the cohort…
2016 International Congress
Non-motor symptoms in advanced Parkinson’s disease patients treated with levodopa/carbidopa intestinal gel, deep brain stimulation, or continuous subcutaneous apomorphine: A systematic literature review and pooled analysis
K.R. Chaudhuri, E. Terasawa, Y. Jalundhwala, D. Macaulay, R. Ayyagari, Z.Y. Zhou, T. Marshall, K. Chatamra, A. Yucel, K. Sail (London, United Kingdom)
Objective: To systematically review literature reporting changes in non-motor symptoms (NMS) among patients with advanced PD (APD) treated with levodopa/carbidopa intestinal gel (LCIG), deep brain…